Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited)

v3.21.2
Condensed Interim Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Share Capital [Member]
Contributed Surplus - Warrant Reserve [Member]
Contributed Surplus [Member]
Deficit [Member]
Total
Beginning balance at Dec. 31, 2019 $ 194,217 $ 642 $ 8,304 $ (214,845) $ (11,682)
Beginning balance, share at Dec. 31, 2019 39,907,681        
Statement Line Items [Line Items]          
Issued pursuant to agency agreement $ 12,819       12,819
Issued pursuant to agency agreement, shares 23,923,700        
March 2020 Equity Offering - broker warrants $ (26) 26      
Common stock equivalents converted $ 1       1
Common stock equivalents converted, shares 8,000,000        
Share issue expense $ (488)       (488)
Warrants exercised $ 2,911       2,911
Warrants exercised, shares 3,750,000        
Stock-based compensation expense     435   435
Net loss       (1,911) (1,911)
Ending balance at Jun. 30, 2020 $ 209,434 668 8,739 (216,756) 2,085
Ending balance, shares at Jun. 30, 2020 75,581,381        
Beginning balance at Dec. 31, 2020 $ 214,148 1,671 9,401 (239,029) (13,809)
Beginning balance, share at Dec. 31, 2020 83,184,843        
Statement Line Items [Line Items]          
Derivative warrants exercised $ 8,000       8,000
Derivative warrants exercised, shares 8,000,000        
Derivative warrants exercised - fair value adjustment $ 15,722       15,722
January 2021 Equity Offering, net of issuance costs $ 7,067 3,164     10,231
January 2021 Equity Offering, net of issuance costs, shares 7,419,354        
January 2021 Equity Offering-broker warrants $ (1,384) 1,384      
February 2021 Equity Offering, net of issuance costs $ 15,165 5,928     21,093
February 2021 Equity Offering, net of issuance costs, shares 9,585,250        
February 2021 Equity Offering-broker warrants $ (1,238) 1,238      
Equity warrants exercised $ 1,985       1,985
Equity warrants exercised, shares 1,318,675        
Options exercised $ 27   (13)   14
Options exercised, shares 19,568        
Issuance of common shares $ 2,524       2,524
Issuance of common shares, shares 1,400,000        
Stock-based compensation expense     2,198   2,198
Net loss       (15,734) (15,734)
Ending balance at Jun. 30, 2021 $ 262,016 $ 13,385 $ 11,586 $ (254,763) $ 32,224
Ending balance, shares at Jun. 30, 2021 110,927,690       110,927,690